Comment on Why Nabriva Therapeutics Stock Is Falling Today

Why Nabriva Therapeutics Stock Is Falling Today

After the company announced top-line data from an important phase 3 trial, shares of Nabriva Therapeutics (NASDAQ: NBRV), a clinical-stage biotech focused on next-generation antibiotics, fell as much as 14% in morning trading on Monday. As of 11:20 a.m. EDT, the stock was down 9%.Nabriva announced top-line results from its Leap 2 study today.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News